ADAR1 Capital Management’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $367K | Sell |
53,349
-437,183
| -89% | -$3.01M | 0.06% | 125 |
|
|
2025
Q1 | $1.41M | Buy |
490,532
+294,284
| +150% | +$848K | 0.26% | 64 |
|
|
2024
Q4 | $922K | Buy |
196,248
+140,446
| +252% | +$660K | 0.18% | 80 |
|
|
2024
Q3 | $199K | Sell |
55,802
-312,567
| -85% | -$1.12M | 0.03% | 153 |
|
|
2024
Q2 | $2.28M | Buy |
368,369
+28,544
| +8% | +$177K | 0.43% | 37 |
|
|
2024
Q1 | $3.21M | Sell |
339,825
-297,580
| -47% | -$2.81M | 0.73% | 22 |
|
|
2023
Q4 | $4.3M | Buy |
+637,405
| New | +$4.3M | 1.54% | 15 |
|